Pacira BioSciences Quarterly Income Statements Chart
Quarterly
|
Annual
Pacira BioSciences Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net product sales | 180,347,000 | 167,594,000 | 187,253,000 | 167,722,000 | 176,387,000 | 165,824,000 | 179,764,000 | 163,583,000 | 169,467,000 | 159,431,000 | 171,587,000 | 166,560,000 | 168,581,000 | 157,422,000 | 158,574,000 | 126,791,000 | 134,863,000 | 118,738,000 | 129,764,000 | 116,889,000 | 75,216,000 | 104,745,000 | 121,846,000 | 104,350,000 | 101,824,000 | 90,906,000 | 94,714,000 | 82,708,000 | 80,717,000 | 74,287,000 | 78,827,000 | 66,951,000 | 70,139,000 | 68,425,000 | 71,764,000 | 66,119,000 | 67,687,000 | 64,502,000 | 68,190,000 | 61,150,000 | 58,062,000 | 57,086,000 | 60,829,000 | 50,920,000 | 46,034,000 | 35,742,000 | 32,436,000 | 22,408,000 | 16,278,000 | 10,835,000 | 4,550,000 | 4,981,000 | ||||||
| royalty revenue | 752,000 | 1,329,000 | 851,000 | 1,636,000 | 1,293,000 | 1,480,000 | 343,000 | 910,000 | 368,000 | 906,000 | 830,000 | 569,000 | 620,000 | 931,000 | 602,000 | 289,000 | 1,210,000 | 595,000 | 289,000 | 939,000 | 578,000 | 335,000 | 780,000 | 407,000 | 400,000 | 740,000 | 390,000 | 320,000 | 225,000 | 358,000 | 665,000 | 652,000 | 781,000 | 879,000 | 597,000 | 616,000 | 774,000 | 706,000 | 730,000 | 874,000 | 606,000 | 771,000 | 809,000 | 668,000 | 886,000 | 608,000 | 620,000 | 509,000 | 452,000 | 763,000 | ||||||||
| total revenues | 181,099,000 | 168,923,000 | 187,253,000 | 168,573,000 | 178,023,000 | 167,117,000 | 181,244,000 | 163,926,000 | 169,467,000 | 160,341,000 | 171,955,000 | 167,466,000 | 169,411,000 | 157,991,000 | 159,194,000 | 127,722,000 | 135,590,000 | 119,027,000 | 130,974,000 | 117,484,000 | 75,505,000 | 105,684,000 | 122,424,000 | 104,685,000 | 102,604,000 | 91,313,000 | 95,114,000 | 83,448,000 | 84,107,000 | 74,607,000 | 79,078,000 | 67,335,000 | 70,934,000 | 69,283,000 | 72,902,000 | 68,355,000 | 69,640,000 | 65,474,000 | 69,321,000 | 62,213,000 | 59,148,000 | 58,316,000 | 61,792,000 | 52,048,000 | 47,165,000 | 36,662,000 | 33,565,000 | 23,259,000 | 17,141,000 | 11,587,000 | 8,486,000 | 12,344,000 | 7,804,000 | 4,233,000 | 3,956,000 | 3,636,000 | 3,863,000 | |
| operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cost of goods sold | 40,866,000 | 34,306,000 | 39,886,000 | 38,864,000 | 44,262,000 | 47,416,000 | 47,692,000 | 39,750,000 | 48,207,000 | 49,020,000 | 61,916,000 | 50,678,000 | 50,627,000 | 36,074,000 | 39,007,000 | 34,651,000 | 35,248,000 | 31,349,000 | 35,297,000 | 29,993,000 | 22,305,000 | 29,732,000 | 31,903,000 | 22,304,000 | 25,201,000 | 27,303,000 | 23,979,000 | 19,065,000 | 20,916,000 | 22,885,000 | 21,294,000 | 18,228,000 | 23,811,000 | 24,581,000 | 23,621,000 | 43,152,000 | 23,053,000 | 20,278,000 | 19,428,000 | 15,901,000 | 18,929,000 | 17,580,000 | 14,618,000 | 20,391,000 | 19,954,000 | |||||||||||||
| research and development | 28,200,000 | 25,342,000 | 23,897,000 | 19,104,000 | 20,338,000 | 18,238,000 | 19,463,000 | 20,830,000 | 18,824,000 | 17,140,000 | 17,505,000 | 19,405,000 | 26,282,000 | 21,605,000 | 15,514,000 | 11,578,000 | 12,573,000 | 15,879,000 | 15,331,000 | 14,651,000 | 13,620,000 | 15,819,000 | 19,653,000 | 20,255,000 | 17,827,000 | 14,384,000 | 14,174,000 | 14,897,000 | 12,239,000 | 14,378,000 | 10,028,000 | 11,775,000 | 18,856,000 | 16,632,000 | 17,069,000 | 9,754,000 | 9,362,000 | 9,493,000 | 13,153,000 | 5,893,000 | 3,649,000 | 5,967,000 | 3,887,000 | 4,425,000 | 5,216,000 | 5,204,000 | 4,836,000 | 5,962,000 | 4,857,000 | 5,905,000 | 3,527,000 | 1,872,000 | 1,294,000 | 2,636,000 | 4,344,000 | 4,381,000 | 3,513,000 | |
| selling, general and administrative | 88,578,000 | 86,776,000 | 79,614,000 | 74,333,000 | 68,126,000 | 72,026,000 | 65,801,000 | 67,947,000 | 64,850,000 | 70,843,000 | 63,970,000 | 61,283,000 | 65,003,000 | 64,260,000 | 51,203,000 | 48,807,000 | 50,813,000 | 48,522,000 | 52,833,000 | 52,561,000 | 43,342,000 | 44,780,000 | 54,223,000 | 50,128,000 | 49,126,000 | 48,518,000 | 44,646,000 | 44,179,000 | 44,249,000 | 44,191,000 | 39,178,000 | 40,644,000 | 39,552,000 | 42,120,000 | 34,673,000 | 36,314,000 | 43,669,000 | 37,957,000 | 37,553,000 | 35,310,000 | 34,752,000 | 31,428,000 | 31,019,000 | 28,217,000 | 24,837,000 | 22,589,000 | 20,172,000 | 15,320,000 | 14,080,000 | 12,936,000 | 11,378,000 | 10,413,000 | 11,152,000 | 6,694,000 | 4,988,000 | 4,671,000 | 3,805,000 | |
| amortization of acquired intangible assets | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 14,322,000 | 7,653,000 | 1,967,000 | 1,967,000 | 1,967,000 | 1,966,000 | 1,967,000 | 1,967,000 | 1,967,000 | 1,967,000 | 1,967,000 | 1,770,000 | |||||||||||||||||||||||||||||||||
| contingent consideration (gains) charges, acquisition-related expenses, restructuring and other | 634,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 172,600,000 | 166,933,000 | 162,549,000 | 308,100,000 | 149,783,000 | 153,905,000 | 148,076,000 | 146,205,000 | 129,590,000 | 163,432,000 | 181,848,000 | 146,177,000 | 138,176,000 | 140,598,000 | 154,983,000 | 96,289,000 | 100,747,000 | 99,590,000 | 112,192,000 | 99,864,000 | 82,652,000 | 88,590,000 | 120,710,000 | 102,272,000 | 97,329,000 | 90,234,000 | 82,852,000 | 79,400,000 | 77,566,000 | 81,544,000 | 70,614,000 | 70,907,000 | 86,714,000 | 83,333,000 | 75,363,000 | 89,220,000 | 76,084,000 | 67,728,000 | 70,134,000 | 57,104,000 | 57,330,000 | 54,975,000 | 53,874,000 | 53,033,000 | 50,007,000 | 45,920,000 | 43,384,000 | 36,073,000 | 29,151,000 | 30,232,000 | 24,192,000 | 18,970,000 | 18,941,000 | 18,950,000 | 12,689,000 | 12,167,000 | 10,985,000 | |
| income from operations | 8,499,000 | 1,990,000 | 24,704,000 | -139,527,000 | 28,240,000 | 13,212,000 | 33,168,000 | 17,721,000 | 39,877,000 | -3,091,000 | -9,893,000 | 21,289,000 | 31,235,000 | 17,393,000 | 4,211,000 | 31,433,000 | 34,843,000 | 19,437,000 | 18,782,000 | 17,620,000 | -7,147,000 | 17,094,000 | 1,714,000 | 2,413,000 | 5,275,000 | 1,079,000 | 12,262,000 | 4,048,000 | 6,541,000 | -6,937,000 | 8,464,000 | -3,572,000 | -15,780,000 | -14,050,000 | -2,461,000 | -20,865,000 | -6,444,000 | -2,254,000 | -813,000 | 5,109,000 | 1,818,000 | 3,341,000 | 7,918,000 | -985,000 | -2,842,000 | -9,258,000 | -9,819,000 | -12,814,000 | -8,531,000 | -7,122,000 | ||||||||
| yoy | -69.90% | -84.94% | -25.52% | -887.35% | -29.18% | -527.43% | -435.27% | -16.76% | 27.67% | -117.77% | -334.93% | -32.27% | -10.36% | -10.52% | -77.58% | 78.39% | -587.52% | 13.71% | 995.80% | 630.21% | -235.49% | 1484.24% | -86.02% | -40.39% | -19.35% | -115.55% | 44.87% | -213.33% | -141.45% | -50.63% | -443.93% | -82.88% | 144.88% | 523.34% | 202.71% | -508.40% | -454.46% | -167.46% | -110.27% | -618.68% | -163.97% | -136.09% | -180.64% | -92.31% | ||||||||||||||
| qoq | 327.09% | -91.94% | -117.71% | -594.08% | 113.75% | -60.17% | 87.17% | -55.56% | -1390.10% | -68.76% | -146.47% | -31.84% | 79.58% | 313.04% | -86.60% | -9.79% | 79.26% | 3.49% | 6.59% | -346.54% | -141.81% | 897.32% | -28.97% | -54.26% | 388.88% | -91.20% | 202.92% | -38.11% | -194.29% | -181.96% | -336.95% | -77.36% | 12.31% | 470.91% | -88.21% | 223.79% | 185.89% | 177.24% | -115.91% | 181.02% | -45.59% | -57.81% | -903.86% | -65.34% | -69.30% | -5.71% | -23.37% | 19.78% | ||||||||||
| operating margin % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other income: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | 5,008,000 | 6,895,000 | 5,555,000 | 5,482,000 | 4,749,000 | 3,903,000 | 3,425,000 | 2,766,000 | 2,111,000 | 3,142,000 | 2,785,000 | 1,234,000 | 252,000 | 271,000 | 80,000 | 177,000 | 224,000 | 415,000 | 693,000 | 1,025,000 | 1,323,000 | 1,589,000 | 1,667,000 | 1,736,000 | 1,817,000 | 2,156,000 | 2,004,000 | 1,586,000 | 1,533,000 | 1,374,000 | 1,273,000 | 1,068,000 | 1,224,000 | 514,000 | 400,000 | 346,000 | 324,000 | 252,000 | 174,000 | 171,000 | 177,000 | 155,000 | 145,000 | 134,000 | 61,000 | 42,000 | 52,000 | 62,000 | 72,000 | 73,000 | 87,000 | 68,000 | 63,000 | 144,000 | 46,000 | 37,000 | 29,000 | |
| interest expense | -4,695,000 | -4,580,000 | -4,680,000 | -4,689,000 | -3,884,000 | -3,316,000 | -3,388,000 | -3,464,000 | -3,865,000 | -9,589,000 | -11,041,000 | -9,856,000 | -8,833,000 | -10,246,000 | -10,423,000 | -7,333,000 | -7,023,000 | -6,971,000 | -7,062,000 | -7,132,000 | -5,456,000 | -6,022,000 | -5,997,000 | -5,940,000 | -5,878,000 | -5,814,000 | -5,754,000 | -5,642,000 | -5,397,000 | -5,157,000 | -5,105,000 | -5,127,000 | -5,226,000 | -2,589,000 | -1,858,000 | -1,601,000 | -1,733,000 | -1,868,000 | -1,883,000 | -1,905,000 | -1,940,000 | -1,996,000 | -2,056,000 | -2,037,000 | -2,079,000 | -2,107,000 | -1,928,000 | -1,892,000 | -676,000 | -2,481,000 | ||||||||
| gain on early extinguishment of debt | 7,518,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| other | -10,739,000 | 4,401,000 | -53,000 | -122,000 | -39,000 | -159,000 | 515,000 | -422,000 | -269,000 | -10,000 | 81,000 | -10,598,000 | -647,000 | -124,000 | -66,000 | -46,000 | -2,396,000 | -157,000 | 281,000 | 2,708,000 | 3,969,000 | -4,104,000 | -925,000 | -4,025,000 | -87,000 | 61,000 | -189,000 | -694,000 | -78,000 | 75,000 | -2,000 | 79,000 | 80,000 | 10,000 | -74,000 | -8,000 | -47,000 | 48,000 | -83,000 | -8,000 | 43,000 | -117,000 | -39,000 | -43,000 | -41,000 | -34,000 | -17,000 | -8,000 | 10,000 | -22,000 | 110,000 | |||||||
| total other income | -10,426,000 | 6,716,000 | 822,000 | 671,000 | 8,344,000 | 428,000 | 552,000 | -1,120,000 | -2,023,000 | -23,383,000 | -8,175,000 | -19,220,000 | -9,228,000 | -10,099,000 | -10,409,000 | -7,202,000 | -9,195,000 | -6,713,000 | -6,088,000 | -11,470,000 | -164,000 | -8,537,000 | -5,255,000 | -8,229,000 | -4,148,000 | -3,597,000 | -3,939,000 | -4,750,000 | -3,942,000 | -3,708,000 | -3,834,000 | -3,980,000 | -3,933,000 | -5,786,000 | -1,532,000 | -1,263,000 | -1,456,000 | -1,568,000 | -1,793,000 | -1,742,000 | -1,771,000 | -2,029,000 | -1,943,000 | -2,019,000 | -2,195,000 | -2,219,000 | -2,137,000 | -1,970,000 | -232,000 | -2,653,000 | ||||||||
| income before income taxes | -1,927,000 | 8,706,000 | 25,526,000 | -138,856,000 | 36,584,000 | 13,640,000 | 33,720,000 | 16,601,000 | 37,854,000 | -26,474,000 | -18,068,000 | 2,069,000 | 22,007,000 | 7,294,000 | -6,198,000 | 24,231,000 | 25,648,000 | 12,724,000 | 12,694,000 | 6,150,000 | -7,311,000 | 8,557,000 | -3,541,000 | -5,816,000 | 1,127,000 | -2,518,000 | 8,323,000 | -702,000 | 2,599,000 | -10,645,000 | 4,630,000 | -7,552,000 | -19,713,000 | -19,836,000 | -3,993,000 | -22,128,000 | -7,900,000 | -3,822,000 | -2,606,000 | 3,367,000 | 47,000 | 1,312,000 | 5,975,000 | -3,004,000 | -5,037,000 | -11,477,000 | -11,956,000 | -14,784,000 | ||||||||||
| income tax expense | -2,920,000 | -3,894,000 | -6,742,250 | -4,610,000 | -17,698,000 | -2,724,000 | -5,743,000 | -12,091,000 | -1,339,750 | -2,762,000 | -2,131,000 | -466,000 | -2,355,000 | -398,000 | -253,000 | -35,000 | -35,000 | -35,000 | -45,000 | -30,000 | -30,000 | 21,000 | -36,000 | -58,000 | -32,000 | -93,000 | -281,000 | -39,000 | -52,000 | |||||||||||||||||||||||||||||
| net income | -4,847,000 | 4,812,000 | 16,041,000 | -143,466,000 | 18,886,000 | 8,979,000 | 24,870,000 | 10,858,000 | 25,763,000 | -19,536,000 | -10,102,000 | -693,000 | 19,876,000 | 6,828,000 | -5,130,000 | 17,660,000 | 19,081,000 | 10,369,000 | 14,515,000 | 130,119,000 | -7,269,000 | 8,159,000 | -4,888,000 | -6,087,000 | 2,730,000 | -2,771,000 | 8,285,000 | -640,000 | 2,564,000 | -10,680,000 | 4,595,000 | -7,597,000 | -19,743,000 | -19,866,000 | -3,972,000 | -22,164,000 | -7,958,000 | -3,854,000 | -2,498,000 | 3,086,000 | 8,000 | 1,260,000 | 5,802,000 | -3,004,000 | -5,037,000 | -11,477,000 | -11,956,000 | -14,784,000 | -14,031,000 | -23,138,000 | -15,745,000 | -8,296,000 | -11,894,000 | -15,283,000 | -9,508,000 | -8,763,000 | -9,775,000 | |
| yoy | -125.66% | -46.41% | -35.50% | -1421.29% | -26.69% | -145.96% | -346.19% | -1666.81% | 29.62% | -386.12% | 96.92% | -103.92% | 4.17% | -34.15% | -135.34% | -86.43% | -362.50% | 27.09% | -396.95% | -2237.65% | -366.26% | -394.44% | -159.00% | 851.09% | 6.47% | -74.05% | 80.30% | -91.58% | -112.99% | -46.24% | -215.68% | -65.72% | 148.09% | 415.46% | 59.01% | -818.21% | -99575.00% | -405.87% | -143.05% | -202.73% | -100.16% | -110.98% | -148.53% | -79.68% | -64.10% | -50.40% | -24.06% | 78.21% | 17.97% | 51.40% | 65.60% | -5.33% | 21.68% | |||||
| qoq | -200.73% | -70.00% | -111.18% | -859.64% | 110.34% | -63.90% | 129.05% | -57.85% | -231.87% | 93.39% | 1357.72% | -103.49% | 191.10% | -233.10% | -129.05% | -7.45% | 84.02% | -28.56% | -88.84% | -1890.05% | -189.09% | -266.92% | -19.70% | -322.97% | -198.52% | -133.45% | -1394.53% | -124.96% | -124.01% | -332.43% | -160.48% | -61.52% | -0.62% | 400.15% | -82.08% | 178.51% | 106.49% | 54.28% | -180.95% | 38475.00% | -99.37% | -78.28% | -293.14% | -40.36% | -56.11% | -4.01% | -19.13% | 5.37% | -39.36% | 46.95% | 89.79% | -30.25% | -22.17% | 60.74% | 8.50% | -10.35% | ||
| net income margin % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per common share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic net income per common share | -110 | 0.41 | 0.54 | 0.23 | 0.56 | -0.43 | -0.22 | -0.02 | 0.44 | 0.15 | -0.12 | 0.4 | 0.43 | 0.24 | 0.32 | 3.03 | -0.17 | 0.07 | -0.11 | -0.59 | -0.07 | 0.08 | ||||||||||||||||||||||||||||||||||||
| diluted net income per common share | -110 | 0.39 | 0.52 | 0.23 | 0.51 | -0.43 | -0.22 | -0.02 | 0.4 | 0.15 | -0.11 | 0.39 | 0.42 | 0.23 | 0.31 | 2.94 | -0.17 | 0.06 | -0.11 | -0.59 | -0.07 | 0.08 | ||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 45,459,000 | 46,275,000 | 46,245 | 46,134,000 | 46,174 | 46,499 | 46,222 | 46,416 | 46,088 | 45,949 | 45,521 | 45,831 | 45,501 | 44,869 | 44,262 | 44,476 | 44,145 | 43,833 | 42,671 | 42,928 | 42,221 | 42,032 | 41,384 | 40,796 | 39,806 | 37,236 | 37,312 | 37,181 | 37,020 | 36,540 | 36,663 | 36,481 | 36,235 | |||||||||||||||||||||||||
| diluted | 45,459,000 | 46,526,000 | 46,245 | 46,134,000 | 50,539 | 52,193 | 51,979 | 52,067 | 52,054 | 45,949 | 46,538 | 45,831 | 52,478 | 46,438 | 45,630 | 45,463 | 45,592 | 45,966 | 43,682 | 44,275 | 42,221 | 42,785 | 42,345 | 41,694 | 39,806 | 37,236 | 37,312 | 37,181 | 37,020 | 41,301 | 41,043 | 41,445 | 41,779 | |||||||||||||||||||||||||
| contingent consideration gains, acquisition-related expenses, restructuring and other | 6,187,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted net income per common share | 100 | -625 | -3,110 | 0.19 | 0.19 | -0.12 | -0.15 | -0.07 | 0.2 | -0.02 | 0.06 | -0.26 | -0.298 | -0.19 | -0.49 | -0.52 | -0.21 | -0.1 | 0 | 0.03 | 0.17 | -0.08 | -0.14 | -0.34 | -0.36 | -0.44 | -0.42 | -0.71 | -0.49 | -0.27 | -0.47 | -0.75 | -0.55 | -0.51 | -0.98 | |||||||||||||||||||||||
| goodwill impairment | 163,243,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| contingent consideration (gains) charges, restructuring charges and other | 718,000 | -1,766,000 | 1,903,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| contingent consideration charges (gains), restructuring charges and other | 2,735,000 | -287,500 | 3,356,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| loss on early extinguishment of debt | -16,926,000 | -8,071,000 | -11,000 | -3,721,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income tax benefit | -4,661,000 | 6,938,000 | 1,068,000 | -6,571,000 | -6,567,000 | 1,821,000 | 123,969,000 | 42,000 | 269,750 | -271,000 | 1,603,000 | -2,000 | 62,000 | 442,000 | ||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related (gains) charges, restructuring charges and other | -16,613,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related charges (gains) and other | 12,107,000 | -3,308,000 | 489,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| collaborative licensing and milestone revenue | 125,000 | 3,000,000 | 26,000 | 26,000 | 130,000 | 206,000 | 357,000 | 1,357,000 | 1,356,000 | 356,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related (gains) charges, product discontinuation and other | -18,058,000 | 326,250 | -714,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related charges, product discontinuation and other | 4,337,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related charges (gains), product discontinuation and other | 146,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related loss (gains), product discontinuation and other | 1,873,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related charges (gains) and product discontinuation | -399,750 | 692,000 | 1,418,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related (gains) charges and product discontinuation | -3,708,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| acquisition-related charges and product discontinuation | 3,066,500 | 7,618,000 | 3,405,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted | 41,513 | 41,645 | 41,240 | 40,911 | 40,995 | 40,707 | 40,463 | 40,160 | 37,998 | 35,299 | 35,943 | 35,463 | 33,710,970 | 33,181,895 | 33,359,576 | 33,083,289 | 32,709,298 | 32,436,207 | 30,953,635 | 25,367,306 | 16,437,464 | 17,230,826 | 17,233,146 | 10,014,042 | ||||||||||||||||||||||||||||||||||
| product discontinuation | 29,000 | 53,000 | 1,259,000 | 162,000 | 90,000 | 114,000 | 260,000 | 4,495,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| royalty interest obligation | -71,000 | 7,000 | -73,000 | -136,000 | -120,000 | -244,000 | -132,000 | 378,000 | -8,000 | 116,000 | 429,000 | -311,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| collaborative licensing and development revenue | 267,250 | 357,000 | 356,000 | 356,000 | 357,000 | 357,000 | 322,000 | 252,000 | 243,000 | 243,000 | 243,000 | 243,000 | 3,484,000 | 6,600,000 | 6,490,000 | 1,229,000 | 1,352,000 | 1,283,000 | 1,210,000 | |||||||||||||||||||||||||||||||||||||||
| loss on extinguishment of debt | -12,750 | -51,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cost of revenues | 18,127,000 | 18,376,000 | 14,791,000 | 10,214,000 | 11,391,000 | 9,287,000 | 6,685,000 | 6,495,000 | 6,601,000 | 3,357,000 | 3,115,000 | 3,667,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| supply and royalty revenue | 1,314,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| supply revenue | 1,217,000 | 1,682,000 | 1,469,000 | 1,716,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| royalties | 685,750 | 922,000 | 884,000 | 937,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| total other (expense) |
We provide you with 20 years income statements for Pacira BioSciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Pacira BioSciences stock. Explore the full financial landscape of Pacira BioSciences stock with our expertly curated income statements.
The information provided in this report about Pacira BioSciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.